Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness a 3% CAGR from 2021 to 2027.


Posted September 29, 2021 by danishahmed

Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness a 3% CAGR from 2021 to 2027.

 
Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness a 3% CAGR from 2021 to 2027.
Atrial fibrillation is the most common persistent cardiac arrhythmia disorder worldwide. This leads to a chaotic rhythm due to the degeneration of electrical impulses that occur in the upper ventricle (atrium) of the heart. Old age, diabetes, high blood pressure, obesity, excessive alcohol consumption, chronic kidney disease, and ischemic heart disease are major risk factors for atrial fibrillation. According to the American Heart Association, individuals over the age of 40 have a lifetime risk of developing atrial fibrillation at 25%. Atrial fibrillation leads to increased hospitalization rates, poor quality of life, and increased risk of stroke and death. Atrial fibrillation medications are used to effectively manage disease by regulating heart rate and rhythm by preventing blood clots. Warfarin, Apixaban, Sotalol, Esmolol, Verapamil, and Dofetilide are some of the atrial fibrillation medications currently on the market.



(Get 15% Discount on Buying this Report)
Get Sample at: https://www.orionmarketreports.com/request-sample/?id=53430

Market Segments

Key Players

Pfizer
AstraZeneca
Boehringer Ingelheim International GmbH
Sanofi
Bristol-Myers Squibb Company
Mitsubishi Tanabe Pharma Corporation
Johnson and Johnson
DAIICHI SANKYO COMPANY, LIMITED
GlaxoSmithKline plc


Global Atrial Fibrillation Drugs Market, by Product

Antiarrhythmic Drugs
Anticoagulant Drugs

Global Atrial Fibrillation Drugs Market, by Type

Paroxysmal
Permanent
Persistent
Global Atrial Fibrillation Drugs Market, by Application
Heart Rate Control
Heart Rhythm Control

A full report is available at : https://www.orionmarketreports.com/atrial-fibrillation-drugs-market/53430/
Scope of the Heart
The research study analyzes the global Atrial Fibrillation Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

For more customized data, request for report customization @ https://www.orionmarketreports.com/inquiry-before-buying/?id=53430
About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Danish Ahmed
Phone +917803040404
Country India
Categories Business
Tags atrial fibrillation drugs market
Last Updated September 29, 2021